Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
Identifieur interne : 000367 ( Pmc/Checkpoint ); précédent : 000366; suivant : 000368Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
Auteurs : Ruth Harvey ; Giada Mattiuzzo ; Mark Hassall ; Andrea Sieberg ; Marcel A. Müller ; Christian Drosten ; Peter Rigsby ; Christopher J. OxenfordSource :
- Emerging Infectious Diseases [ 1080-6040 ] ; 2019.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including
Url:
DOI: 10.3201/eid2510.190497
PubMed: 31423969
PubMed Central: 6759245
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:6759245Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus</title><author><name sortKey="Harvey, Ruth" sort="Harvey, Ruth" uniqKey="Harvey R" first="Ruth" last="Harvey">Ruth Harvey</name></author><author><name sortKey="Mattiuzzo, Giada" sort="Mattiuzzo, Giada" uniqKey="Mattiuzzo G" first="Giada" last="Mattiuzzo">Giada Mattiuzzo</name></author><author><name sortKey="Hassall, Mark" sort="Hassall, Mark" uniqKey="Hassall M" first="Mark" last="Hassall">Mark Hassall</name></author><author><name sortKey="Sieberg, Andrea" sort="Sieberg, Andrea" uniqKey="Sieberg A" first="Andrea" last="Sieberg">Andrea Sieberg</name></author><author><name sortKey="Muller, Marcel A" sort="Muller, Marcel A" uniqKey="Muller M" first="Marcel A." last="Müller">Marcel A. Müller</name></author><author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name></author><author><name sortKey="Rigsby, Peter" sort="Rigsby, Peter" uniqKey="Rigsby P" first="Peter" last="Rigsby">Peter Rigsby</name></author><author><name sortKey="Oxenford, Christopher J" sort="Oxenford, Christopher J" uniqKey="Oxenford C" first="Christopher J." last="Oxenford">Christopher J. Oxenford</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31423969</idno><idno type="pmc">6759245</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759245</idno><idno type="RBID">PMC:6759245</idno><idno type="doi">10.3201/eid2510.190497</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000C22</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C22</idno><idno type="wicri:Area/Pmc/Curation">000C22</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000C22</idno><idno type="wicri:Area/Pmc/Checkpoint">000367</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000367</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus</title><author><name sortKey="Harvey, Ruth" sort="Harvey, Ruth" uniqKey="Harvey R" first="Ruth" last="Harvey">Ruth Harvey</name></author><author><name sortKey="Mattiuzzo, Giada" sort="Mattiuzzo, Giada" uniqKey="Mattiuzzo G" first="Giada" last="Mattiuzzo">Giada Mattiuzzo</name></author><author><name sortKey="Hassall, Mark" sort="Hassall, Mark" uniqKey="Hassall M" first="Mark" last="Hassall">Mark Hassall</name></author><author><name sortKey="Sieberg, Andrea" sort="Sieberg, Andrea" uniqKey="Sieberg A" first="Andrea" last="Sieberg">Andrea Sieberg</name></author><author><name sortKey="Muller, Marcel A" sort="Muller, Marcel A" uniqKey="Muller M" first="Marcel A." last="Müller">Marcel A. Müller</name></author><author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name></author><author><name sortKey="Rigsby, Peter" sort="Rigsby, Peter" uniqKey="Rigsby P" first="Peter" last="Rigsby">Peter Rigsby</name></author><author><name sortKey="Oxenford, Christopher J" sort="Oxenford, Christopher J" uniqKey="Oxenford C" first="Christopher J." last="Oxenford">Christopher J. Oxenford</name></author></analytic><series><title level="j">Emerging Infectious Diseases</title><idno type="ISSN">1080-6040</idno><idno type="eISSN">1080-6059</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including <underline>></underline>2 tests to ensure correct diagnosis of MERS-CoV. We also demonstrate that the use of a reference reagent greatly improves the agreement between assays, enabling more consistent and therefore more meaningful comparisons between results.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id><journal-id journal-id-type="publisher-id">EID</journal-id><journal-title-group><journal-title>Emerging Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control and Prevention</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31423969</article-id><article-id pub-id-type="pmc">6759245</article-id><article-id pub-id-type="publisher-id">19-0497</article-id><article-id pub-id-type="doi">10.3201/eid2510.190497</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research</subject></subj-group><subj-group subj-group-type="TOC-title"><subject>Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus</subject></subj-group></article-categories><title-group><article-title>Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus</article-title><alt-title alt-title-type="running-head">Comparison of Serologic Assays for MERS-CoV </alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Harvey</surname><given-names>Ruth</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Mattiuzzo</surname><given-names>Giada</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hassall</surname><given-names>Mark</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sieberg</surname><given-names>Andrea</given-names></name></contrib><contrib contrib-type="author"><name><surname>Müller</surname><given-names>Marcel A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Drosten</surname><given-names>Christian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rigsby</surname><given-names>Peter</given-names></name></contrib><contrib contrib-type="author"><name><surname>Oxenford</surname><given-names>Christopher J.</given-names></name></contrib><contrib contrib-type="author"><collab>study participants</collab><xref ref-type="fn" rid="FN1"><sup>1</sup></xref></contrib><aff id="aff1">National Institute for Biological Standards and Control—MHRA, Potters Bar, UK (R. Harvey, G. Mattiuzzo, M. Hassall, P. Rigsby);</aff><aff id="aff2">Charité-Universitätsmedizin Berlin, Berlin, Germany (A. Sieberg, M.A. Müller, C. Drosten);</aff><aff id="aff3">German Centre for Infection Research, Berlin (M.A. Müller, C. Drosten);</aff><aff id="aff4">World Health Organization, Lyon, France (C.J. Oxenford).</aff></contrib-group><author-notes><corresp id="cor1">Address for correspondence: Giada Mattiuzzo, NIBSC, Division of Virology, Blanche Lane, South Mimms, Hertfordshire EN6 3QG, UK; email: <email xlink:href="Giada.Mattiuzzo@nibsc.org">Giada.Mattiuzzo@nibsc.org</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2019</year></pub-date><volume>25</volume><issue>10</issue><fpage>1878</fpage><lpage>1883</lpage><abstract><p>Middle East respiratory syndrome coronavirus (MERS-CoV) was detected in humans in 2012. Since then, sporadic outbreaks with primary transmission through dromedary camels to humans and outbreaks in healthcare settings have shown that MERS-CoV continues to pose a threat to human health. Several serologic assays for MERS-CoV have been developed globally. We describe a collaborative study to investigate the comparability of serologic assays for MERS-CoV and assess any benefit associated with the introduction of a standard reference reagent for MERS-CoV serology. Our study findings indicate that, when possible, laboratories should use a testing algorithm including <underline>></underline>2 tests to ensure correct diagnosis of MERS-CoV. We also demonstrate that the use of a reference reagent greatly improves the agreement between assays, enabling more consistent and therefore more meaningful comparisons between results.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Middle East respiratory syndrome coronavirus</kwd><kwd>MERS-CoV</kwd><kwd>antibodies</kwd><kwd>diagnostics</kwd><kwd>standard</kwd><kwd>serology</kwd><kwd>viruses</kwd><kwd>Oman</kwd><kwd>Saudi Arabia</kwd><kwd>South Korea</kwd></kwd-group></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name><name sortKey="Harvey, Ruth" sort="Harvey, Ruth" uniqKey="Harvey R" first="Ruth" last="Harvey">Ruth Harvey</name><name sortKey="Hassall, Mark" sort="Hassall, Mark" uniqKey="Hassall M" first="Mark" last="Hassall">Mark Hassall</name><name sortKey="Mattiuzzo, Giada" sort="Mattiuzzo, Giada" uniqKey="Mattiuzzo G" first="Giada" last="Mattiuzzo">Giada Mattiuzzo</name><name sortKey="Muller, Marcel A" sort="Muller, Marcel A" uniqKey="Muller M" first="Marcel A." last="Müller">Marcel A. Müller</name><name sortKey="Oxenford, Christopher J" sort="Oxenford, Christopher J" uniqKey="Oxenford C" first="Christopher J." last="Oxenford">Christopher J. Oxenford</name><name sortKey="Rigsby, Peter" sort="Rigsby, Peter" uniqKey="Rigsby P" first="Peter" last="Rigsby">Peter Rigsby</name><name sortKey="Sieberg, Andrea" sort="Sieberg, Andrea" uniqKey="Sieberg A" first="Andrea" last="Sieberg">Andrea Sieberg</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000367 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000367 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:6759245
|texte= Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:31423969" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |